Cargando…
Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction
PURPOSE: Hepatocellular carcinoma (HCC) is the fourth commonest cause of cancer-related mortality; it is associated with various genetic alterations, some involved in metabolic reprogramming. This study aimed to explore the potential metabolic impact of Carbamoyl Phosphate Synthase I (CPS1) and carb...
Autores principales: | Dumenci, Ozbil E, U, Abellona MR, Khan, Shahid A, Holmes, Elaine, Taylor-Robinson, Simon D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955626/ https://www.ncbi.nlm.nih.gov/pubmed/32021853 http://dx.doi.org/10.2147/JHC.S239039 |
Ejemplares similares
-
Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma
por: Ridder, Dirk Andreas, et al.
Publicado: (2021) -
The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery
por: Shen, Eric Yi-Liang, et al.
Publicado: (2023) -
The utility of biomarkers in hepatocellular carcinoma: review of urine-based (1)H-NMR studies – what the clinician needs to know
por: Cartlidge, Caroline R, et al.
Publicado: (2017) -
CPS pre-injector beam measurements
por: Tallgren, U
Publicado: (1961) -
CPS pre-injector beam measurements
por: Tallgren, U
Publicado: (1961)